154 related articles for article (PubMed ID: 18386881)
41. Arachidonic acid metabolites inhibit the stimulatory effect of angiotensin II in renal proximal tubules.
Li Y; Yamada H; Kita Y; Suzuki M; Endo Y; Horita S; Yamazaki O; Shimizu T; Seki G; Fujita T
Hypertens Res; 2008 Dec; 31(12):2155-64. PubMed ID: 19139605
[TBL] [Abstract][Full Text] [Related]
42. Targeting the insulin-regulated aminopeptidase/AT4 receptor for cognitive disorders.
Hallberg M
Drug News Perspect; 2009 Apr; 22(3):133-9. PubMed ID: 19440555
[TBL] [Abstract][Full Text] [Related]
43. Alzheimer's, angiotensin IV and an aminopeptidase.
Albiston AL; Fernando R; Ye S; Peck GR; Chai SY
Biol Pharm Bull; 2004 Jun; 27(6):765-7. PubMed ID: 15187413
[TBL] [Abstract][Full Text] [Related]
44. Novel 3-galloylamido-N'-substituted-2,6-piperidinedione-N-acetamide peptidomimetics as metalloproteinase inhibitors.
Li Q; Fang H; Xu W
Bioorg Med Chem Lett; 2007 May; 17(10):2935-8. PubMed ID: 17433673
[TBL] [Abstract][Full Text] [Related]
45. Biostable agonists that match or exceed activity of native insect kinins on recombinant arthropod GPCRs.
Taneja-Bageshwar S; Strey A; Isaac RE; Coast GM; Zubrzak P; Pietrantonio PV; Nachman RJ
Gen Comp Endocrinol; 2009 May; 162(1):122-8. PubMed ID: 18983996
[TBL] [Abstract][Full Text] [Related]
46. Identification of selective and non-selective, biostable beta-amino acid agonists of recombinant insect kinin receptors from the southern cattle tick Boophilus microplus and mosquito Aedes aegypti.
Taneja-Bageshwar S; Strey A; Zubrzak P; Williams H; Reyes-Rangel G; Juaristi E; Pietrantonio P; Nachman RJ
Peptides; 2008 Feb; 29(2):302-9. PubMed ID: 18207610
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, structure-activity relationships and brain uptake of a novel series of benzopyran inhibitors of insulin-regulated aminopeptidase.
Mountford SJ; Albiston AL; Charman WN; Ng L; Holien JK; Parker MW; Nicolazzo JA; Thompson PE; Chai SY
J Med Chem; 2014 Feb; 57(4):1368-77. PubMed ID: 24471437
[TBL] [Abstract][Full Text] [Related]
48. Angiotensin II analogues with N-terminal lactam bridge cyclization: an overview on AT
Alves FL; Oliveira VX; Miranda A
Chem Biol Drug Des; 2016 Nov; 88(5):677-682. PubMed ID: 27230954
[TBL] [Abstract][Full Text] [Related]
49. IRAP and AT(1) receptor mediated effects of angiotensin IV.
Dupont AG; Yang R; Smolders I; Vanderheyden P
J Intern Med; 2009 Mar; 265(3):401-3; author reply 404-5. PubMed ID: 19207373
[No Abstract] [Full Text] [Related]
50. Novel hydroxamic acid-related phosphinates: inhibition of neutral aminopeptidase N (APN).
Drag M; Grzywa R; Oleksyszyn J
Bioorg Med Chem Lett; 2007 Mar; 17(6):1516-9. PubMed ID: 17270439
[TBL] [Abstract][Full Text] [Related]
51. Rapid and efficient synthesis of a novel series of substituted aminobenzosuberone derivatives as potent, selective, non-peptidic neutral aminopeptidase inhibitors.
Albrecht S; Salomon E; Defoin A; Tarnus C
Bioorg Med Chem; 2012 Aug; 20(16):4942-53. PubMed ID: 22796349
[TBL] [Abstract][Full Text] [Related]
52. Insulin-regulated aminopeptidase: analysis of peptide substrate and inhibitor binding to the catalytic domain.
Ye S; Chai SY; Lew RA; Albiston AL
Biol Chem; 2007 Apr; 388(4):399-403. PubMed ID: 17391061
[TBL] [Abstract][Full Text] [Related]
53. Involvement of redox-sensitive extracellular-regulated kinases in angiotensin II-induced interleukin-6 expression in pancreatic acinar cells.
Chan YC; Leung PS
J Pharmacol Exp Ther; 2009 May; 329(2):450-8. PubMed ID: 19211919
[TBL] [Abstract][Full Text] [Related]
54. Asp218 participates with Asp213 to bind a Ca2+ atom into the S1 subsite of aminopeptidase A: a key element for substrate specificity.
Claperon C; Rozenfeld R; Iturrioz X; Inguimbert N; Okada M; Roques B; Maigret B; Llorens-Cortes C
Biochem J; 2008 Nov; 416(1):37-46. PubMed ID: 18598240
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and pharmacological characterization at glutamate receptors of the four enantiopure isomers of tricholomic acid.
Pinto A; Conti P; De Amici M; Tamborini L; Madsen U; Nielsen B; Christesen T; Bräuner-Osborne H; De Micheli C
J Med Chem; 2008 Apr; 51(7):2311-5. PubMed ID: 18338843
[TBL] [Abstract][Full Text] [Related]
56. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
Zhang YN; Zhang W; Hong D; Shi L; Shen Q; Li JY; Li J; Hu LH
Bioorg Med Chem; 2008 Sep; 16(18):8697-705. PubMed ID: 18707891
[TBL] [Abstract][Full Text] [Related]
57. Novel aminopeptidase N inhibitors derived from 1,3,4-thiadiazole scaffold.
Tu G; Li S; Huang H; Li G; Xiong F; Mai X; Zhu H; Kuang B; Xu WF
Bioorg Med Chem; 2008 Jul; 16(14):6663-8. PubMed ID: 18571419
[TBL] [Abstract][Full Text] [Related]
58. Novel 3-amino-2-hydroxy acids containing protease inhibitors. Part 1: Synthesis and kinetic characterization as aminopeptidase P inhibitors.
Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
Bioorg Med Chem; 2005 Aug; 13(16):4806-20. PubMed ID: 15993089
[TBL] [Abstract][Full Text] [Related]
59. Ablation of angiotensin IV receptor attenuates hypofibrinolysis via PAI-1 downregulation and reduces occlusive arterial thrombosis.
Numaguchi Y; Ishii M; Kubota R; Morita Y; Yamamoto K; Matsushita T; Okumura K; Murohara T
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2102-8. PubMed ID: 19745198
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
